Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
About your search
ABCG2 and congenital myopathy are reported together in 2 articles.
Gene
ABCG2
- HGNC
- HGNC:74
21articles
21mentions
2variants with confirmed gene link
Most co-reported phenotypes (articles)
breast cancer 5HIV infection 2congenital myopathy 2dyslipidemia 2rheumatoid arthritis 2colorectal cancer 1ovarian cancer 1prostate cancer 1
Reported variants (articles · ClinVar status)
Phenotype
Congenital myopathy
134articles
134mentions
12co-reported genes shown
Most co-reported genes (articles)
Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.
Publications
2 records shown · first 60Unveiling hidden risks: pharmacogenetic insights from a cross-sectional study of statin therapy in the Indian population.
PMID 40489054 | DOI 10.1007/s43440-025-00746-1 · Pharmacological reports : PR · 2025 · 6 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ABCG2 | “Hence, we conducted a population-level screening for pharmacogenetic determinants of statin therapy, particularly Solute Carrier Organic Anion Transporter Family Member 1B1 (SLCO1B1) and ATP-binding cassette sub-family G member 2 (ABCG2).” | 0.98 | hgnc_dict_v1 |
| phenotype | congenital myopathy | “BACKGROUND: Statin usage has increased significantly in India due to the very high incidence of dyslipidemia, however, approximately 18% of the population is at risk for statin-induced myopathy.” | 0.93 | phenotype_alias_lexicon_v2 |
| gene | SLCO1B1 | “Hence, we conducted a population-level screening for pharmacogenetic determinants of statin therapy, particularly Solute Carrier Organic Anion Transporter Family Member 1B1 (SLCO1B1) and ATP-binding cassette sub-family G member 2 (ABCG2).” | 0.98 | hgnc_dict_v1 |
| phenotype | dyslipidemia | “BACKGROUND: Statin usage has increased significantly in India due to the very high incidence of dyslipidemia, however, approximately 18% of the population is at risk for statin-induced myopathy.” | 0.98 | phenotype_alias_lexicon_v2 |
The frequency of major ABCG2, SLCO1B1 and CYP2C9 variants in Asian, Native Hawaiian and Pacific Islander women subgroups: implications for personalized statins dosing.
PMID 37222158 | PMCID PMC10242434 | DOI 10.2217/pgs-2023-0043 · Pharmacogenomics · 2023 · 8 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ABCG2 | “The frequency of major ABCG2, SLCO1B1 and CYP2C9 variants in Asian, Native Hawaiian and Pacific Islander women subgroups: implications for personalized statins dosing.” | 0.98 | hgnc_dict_v1 |
| phenotype | congenital myopathy | “Combined phenotype rates for rosuvastatin and fluvastatin revealed that Filipinos and Koreans had the highest frequencies of statin-associated myopathy symptoms risk alleles.” | 0.93 | phenotype_alias_lexicon_v2 |
| gene | SLCO1B1 | “The frequency of major ABCG2, SLCO1B1 and CYP2C9 variants in Asian, Native Hawaiian and Pacific Islander women subgroups: implications for personalized statins dosing.” | 0.98 | hgnc_dict_v1 |
| gene | CYP2C9 | “The frequency of major ABCG2, SLCO1B1 and CYP2C9 variants in Asian, Native Hawaiian and Pacific Islander women subgroups: implications for personalized statins dosing.” | 0.98 | hgnc_dict_v1 |